Search

Laboratory research shows how it may be possible to develop an immunotherapy-based approach for treating aggressive forms of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

… Wednesday, April 23, 2025 The blood cancers acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are extremely challenging to treat. While advances in immunotherapy have cured many patients with other blood cancers, they haven’t been successful for AML and MDS. Together, these diseases kill

Read our key takeaways from the second half of the American Association for Cancer Research’s 2019 annual meeting.

… Monday, April 1, 2019 Summary Memorial Sloan Kettering scientists are presenting data from more than 100 studies at the American Association for Cancer Research’s 2019 annual meeting, held this year in Atlanta. Below is part two of our research roundup. Read part one of our coverage. Early Detection

Learn about the Marie-Josée Kravis Fellowship in Quantitative Biology, a two-year postdoctoral fellowship that aims to build a new generation of skilled quantitative biologists who specialize in cancer.

… Wednesday, April 19, 2023 These days Sneha Mitra, PhD , spends a lot of time thinking about T cells — a type of white blood cell that helps protect the body from infection and cancer. A postdoctoral fellow at the Sloan Kettering Institute , Dr. Mitra is working to understand how the interactions and

Find out what going to therapy is actually like from MSK postdoctoral fellow Kailey Roberts.

… Thursday, September 19, 2019 Summary MSK postdoctoral fellow and licensed clinical psychologist Kailey Roberts shares some popular myths about therapy and what actually happens in a typical session. Anyone facing cancer — whether as a patient or the loved one of someone with the disease — could use psychological

MSK's 44th annual Academic Convocation and Commencement celebrated the Gerstner Sloan Kettering Graduate School of Biomedical Sciences class of 2023, honored students graduating from the Sloan Kettering Division of the Weill Cornell Medicine Graduate School of Medical Sciences, and recognized winners of several awards and fellowships.

… Friday, May 19, 2023 A record number of students graduated this year with doctoral degrees in cancer biology from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) — the educational division of Memorial Sloan Kettering Cancer Center (MSK). There were 17 graduates receiving their

Various facilities provide the services and technology that support Memorial Sloan Kettering’s cancer genomics studies.

… Wednesday, November 14, 2012 Summary Various facilities provide the services and technology that support Memorial Sloan Kettering’s cancer genomics studies. A range of facilities provide expert services and technology to support cancer genomics studies at Memorial Sloan Kettering. The Integrated Genomics

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.

… Tuesday, March 31, 2026 Mesothelioma , a rare cancer that usually starts in the lining around the lungs, has long been thought of as a condition that affects older men — especially those who may have been exposed to asbestos while working in manufacturing or construction. About 3,300 people are diagnosed

Learn how high-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation.

… Monday, June 30, 2025 For people with  prostate cancer  considered “intermediate risk” —  small tumors confined to one area of the prostate – doctors are increasingly using a treatment known as  focal therapy  (partial gland ablation). One approach uses an advanced and highly precise energy source known

Research by a team at Memorial Sloan Kettering Cancer Center has found important new insights into colorectal cancer in Nigeria that have significant implications for treating the disease in West Africa. This research also expands awareness of how different population groups may require different approaches in the diagnosis and treatment of cancer.

… Wednesday, November 24, 2021 Colorectal cancer is common — and deadly — around the world.   But too often, major population groups are not represented in colorectal cancer research, which focuses mainly on patients in America and Western Europe.   A team of researchers from Memorial Sloan Kettering Cancer

The Patient and Family Advisory Council for Quality (PFACQ) marks five years of ensuring the patient and family perspective is included in everything MSK does.

… Wednesday, January 1, 2020 In 2014, Kate Niehaus, a former patient active in volunteer work for Memorial Sloan Kettering, was approached by Kent Sepkowitz, an infectious disease specialist and Deputy Physician-in-Chief for Quality and Safety, with a proposal to make MSK’s outstanding cancer care even